An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Ridgefield, Conn., U.S., and Ingelheim, GermanyZongertinib would be the first orally administered, targeted therapy for previously treated ...

Advancements in nano-catalysts are transforming biofuel production, increasing efficiency and quality while supporting ...

The Botanist' director Jing Yi was mentored by Bi Gan for their Berlinale debut. Watch an exclusive teaser here.

Israel begins planning for Palestinian departures from Gaza, despite international opposition to Trump's proposal. Egypt warns relocating Gaza Palestinians could jeopardize its peace treaty with ...

Additionally, participants will receive remternetug or placebo every 3 months, a less frequent dosing schedule than the bi-weekly or monthly dosing schedules ... $98.3 million from the NIH's National ...

With wildfires ravaging Los Angeles County since the start of the year, Republicans have openly discussed withholding crucial disaster aid for California unless the state makes right-wing policy ...

On this Holocaust Remembrance Day, I have a proposal, one that gets to the very heart of what we’re remembering: that we take this somber moment to consider why it’s wrong to think of any ...

(JTA) — President Donald Trump will allow the delivery of 2,000-pound bombs to Israel, removing a hold his predecessor, Joe Biden, had placed on the ordnance. The change comes during a ceasefire ...

NBC News' Raf Sanchez reports as hostages set free by Hamas in the second round of releases since the Jan. 19 ceasefire arrive in Israel to be treated at a nearby hospital and are greeted by ...